It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Although capsular contracture remains one of the major problems following silicone breast implantation, the associated mechanism has yet to be determined. This study thus aimed to investigate capsule formation and capsular contracture using three types of implants with different surface topographies in vivo. Three types of implants (i.e., smooth, macrotexture, and nanotexture) with different surface topographies were inserted in a total of 48 Wistar rats. After 4 and 12 weeks, the samples were analyzed via histological, immunohistochemical, and Western blot examination. To identify implant movement, the degree to which implant position changed was measured. And the surface topography was characterized using scanning electron microscopy. Hematoxylin–eosin staining showed that the nanotexture type implant promoted significant decreases in capsule thickness at 12 weeks (P < 0.05), while Masson trichrome staining showed decreased collagen fiber density with the same implant type. Immunohistochemical and Western blot examination revealed reduced fibrosis markers (myofibroblast, and transforming growth factor beta-1) in the nanotexture surface implant. Meanwhile, implant location evaluation found that the nanotexture and smooth surface implants had significantly increased movement (P < 0.05). The nanotexture surface implant had been found to reduce capsule formation given that it minimizes the effects of factors related to foreign body reaction.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Kyungpook National University School of Medicine, Department of Plastic and Reconstructive Surgery, Daegu, Korea (GRID:grid.258803.4) (ISNI:0000 0001 0661 1556)
2 Kyungpook National University School of Medicine, Cell and Matrix Research Institute, Daegu, Korea (GRID:grid.258803.4) (ISNI:0000 0001 0661 1556)
3 Kyungpook National University School of Medicine, Exosome Convergence Research Center, Daegu, Korea (GRID:grid.258803.4) (ISNI:0000 0001 0661 1556)
4 Kyungpook National University, Department of Laboratory Animal Medicine, College of Veterinary Medicine, Daegu, Korea (GRID:grid.258803.4) (ISNI:0000 0001 0661 1556)
5 Kyungpook National University School of Medicine, Department of Physiology, Cell and Matrix Research Institute, Daegu, Korea (GRID:grid.258803.4) (ISNI:0000 0001 0661 1556)